"Promoting and supporting research into diabetes
and metabolic diseases".

For the advancement of diabetes research

In the spotlight

The FFRD wishes you a wonderful holiday season!

 

It is with immense gratitude and sincere appreciation that we THANK YOU!

 

  • YOU, generous donors, who have chosen to make diabetes research a priority. Your support is more than just a gesture: it is a beacon of hope for the future!
  • YOU, dedicated researchers, who devote your talent and energy to this noble cause, we extend our heartfelt congratulations. YOU are the architecs of progress!
  • Together, let’s go on writing this beautiful story of scientific progress.

 

The FFRD wishes everyone a 2025 filled with joy, health, and success in your personal and professional endeavors..

 

 

THANK YOU FOR STANDING WITH US IN THIS ESSENTIAL FIGHT!

News

The upcoming events of the FFRD

President’s foreword

Diabetes mellitus affects 5% of the French population and is a major burden for the persons living with this chronic disease, with potentially serious complications and high costs induced. Major and continuous improvements have been made for a botter understanding of the mechanisms of the disease and its complications, and for its monitoring and treatment as well.

The FFRD supports all research on diabetes.

The FFRD supports clinical, basic, and translational research.

The supported basic research projects address major themes of type 1 and type 2 diabetes

covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.

The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes

and often involve large multicenter cohort studies.

Since 2013, the Foundation has been:

0
years of existence
0
teams of supported researchers
0
euros in annual grants
0
million of euros distributed
0
% of expenses allocated to research

The recipients of the year

Pierre GOURDY
Pierre GOURDY
Cardiovascular and Metabolic diseases Institute, Inserm, CHU in Toulouse
Translational Research Project
300 000
Alfonso GALDERISI
Alfonso GALDERISI
Robert Debré, Hospital, University Paris Cité
Clinical Research Project
300 000

They support us